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Résumé
L’intégrase du VIH-1 (IN) est l’enzyme rétrovirale responsable de l’intégration
d’une copie d’ADN viral à double brin dans le chromosome hôte. Ceci constitue une
étape essentielle au cycle de vie viral. Il n’existe actuellement aucune structure de l’IN
du Vifi- 1 de pleine longueur ni aucune structure d’une IN en complexe avec un ADN
substrat. En l’absence de ces informations, des études de modélisation moléculaire et
des études de mutagenèse, telles celles présentées ici, pourraient constituer une
stratégie propice à l’obtention de nouvelles informations structure-fonction sur cette
importante cible pharmacologique. Une banque de balayage par insertion avait été
préalablement produite dans le gène de l’intégrase du VLH-1. La banque a été
produite en utilisant un système de transposase Tn5. Nous avons obtenu une série de
vecteurs contenant chacun une insertion de 57 paires de bases disposées aléatoirement
dans le gène et donnant lieu à une insertion de 19 acides aminés au cours de
l’expression protéique, peu importe le cadre de lecture. Au total, 55 mutants d’insertion
uniques ont été analysés: 2 insertions dans le domaine N-terminal, 29 insertions dans le
noyau catalytique et 24 insertions dans le domaine C-terminal. Les effets de
l’insertion sur l’activité enzymatique ont été déterminés in vitro. Nous avons identifié
trois régions qui ont fonctionnellement toléré diverses insertions. Celles-ci
correspondent à la jonction entre le domaine N-terminal et le noyau catalytique, à la
jonction entre le noyau catalytique et le domaine C-terminal et au domaine C-terminal
de l’iN. Ces résultats corrèlent avec des études de délétion délimitant les limites des
domaines et des sous-domaines de diverses iNs.
Mots-clés : VIH- 1, intégrase, transposon 1n5
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Summary
HIV-1 integrase (IN) is the retroviral protein responsible for the insertion of a
double-stranded DNA copy into host chromosome, which is an essential step during the
viral life cycle. As of today, there is presently no structure available for any IN
complexed with a DNA substrate, and no full-length experimental structure of HW- 1 IN
is available. In the absence of this information, molecular modeling studies and
mutational studies, such as the ones presented here, might be a good strategy to explore
a possible solution for obtaining structure-function information on this
pharmacologically important enzyme. A linker-scanning library was previously
generated within the HW- 1 integrase gene. The library was generated using a Tn5
transposition system and resulted in a series of vectors each containing a single 57 base
pair insertion at random locations. Insertions resulted in 19-amino acid in-frame
insertions. A total of 55 unique insertion mutants were analyzed: 2 insertions within the
N-terminal domain, 29 insertions within the catalytic core and 24 insertions within the
C-terminal domain. The effects of the insertions on enzymatic activity were determined
in vitro. Three regions were identified that functionally tolerated various
linker-insertions. These correspond to the N-terminal domainlcatalytic core junction, the
junction between the IN catalytic core and the C-terminal domain and the C-terminal
domain of IN. These resuits correlate with deletional studies mapping the domain and
sub-domain boundaries ofvarious IN.
Keywords: HW- 1, integrase, Tn5 transposon
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1Chapter I
Introduction
Acquired immunodeficiency syndrome (ADS) is caused by the human
immunodeficiency virus (HIV). HW is a retrovirus belonging to the lentivirus family
that was unknown until the early 1980’s, but since that time has been spread around the
world and has infected millions of persons[l]. The mature HW retrovirus core has two
short strands of RNA 9200 nucleotide bases long--along with the enzymes reverse
transcriptase, protease, ribonuclease, and integrase (IN). The core of the retrovirus is
encased in an outer lipid envelope containing an antigen, gp120, which plays a role in
the binding ofthe virus to the target celis with CD4 receptors[2]. The gene content ofthe
HW genome, similar to other retroviruses, has three major genes--gag, pol, and env[3].
Afier entering the body, HIV retrovirus enters the target celi via the CD4 receptor. The
HIV particle uncoats from the envelope to release its RNA into the cellular cytoplasm.
Its RNA genome is transcribed into proviral DNA by reverse transcriptase bound to the
HW RNA, which is one of the enzyme products of the p01 gene. HW proviral DNA is
then inserted into host cell genomic DNA by the iN enzyme. Once the HIV proviral
DNA is within the infected cell’s genome, it becomes part of the host genome. The host
cell can replicate the HIV provirus. The infected ceil can undergo lysis with release of
new HIV virions, which in tum can infect additional cells. Current antiviral drugs are
either inhibitors of HW reverse transcriptase (RT) or protease (PR) but no drugs against
IN are available yet. HIV IN is a good target for drug discovery, since IN is essential for
retroviral replication and production of new virus; moreover, it has no obvious
1
7functional analogue in the host (Fig.1.1).
In this thesis, the HW-1 IN gene was subjected to random insertion mutagenesis.
Jndividual constructs, selected from the library, were assayed for the effects on iN
functions in vitro. The effect of individual insertion on enzymatic activity were analyzed
in the context of HW-1 monomer, dimer and tetramer model withlwithout DNA to gain
insight into the organization of the HW- 1 integrase complex with DNA. One aim of this
mutational analysis was to identify sites within the IN protein that may tolerate small
insertional tags whose function may alter the target-site selection of the viral integrases.
Another aim is to compare available tetramer models with our experimental data to see
how they agree with ours and existing biochemical data. Moreover, the domain
boundaries defined in this study might be useful in expressing minimized iN constructs
for crystallization studies.
1.1 111V-1 Integrase
Integrase catalyzes the integration of a double-stranded DNA copy of the retroviral
RNA genome into the genome of a host[4]. This DNA integration reaction requires
specific sequences at the 3’ and 5’ termini of the viral DNA (referred to as U3 and
U5, respectively, in reference to their unique character) and can be done using
purified IN alone in vitro [5]. The integration reaction is carried out in two steps:
3’-end processing, which is a hydrolytic cleavage, occurs two bases from the 3’ end of
the U3 and U5 termini, just 3’ of a conserved CA dinucleotide, and strand transfer:
the 3’-end processing reaction exposes the free 3’-hydroxyl, which is then used to
perform a nucleophilic attack on the target DNA. The sites ofnucleophilic attack on
the two strands of the target DNA are separated by 5 bp. The 5’ ends of the viral
DNA are left unjoined in the resulting integration intermediate. The removal of the
2
3two unpaired nucleotides at each 5’ end of the viral DNA, gap fihling, and ligation
are likely to be carried out by host enzymes[6, 7]. An in vitro reconstructed system
using purified IN enzyme and model DNA substrates that consist of short
oligodeoxynucleotide duplexes has been employed to explore the details of the
biochemistry of IN and its catalytic mechanism (fig. 1.2). This short
oligodeoxynucleotide duplex substrate mimics the U5 or U3 ends of the viral DNA [6,
8]. Blunt-ended viral substrates can be properly processed at their 3’ ends in vitro,
and the processed substrates can subsequently be used as a strand transfer substrate
and inserted into a target DNA. In addition, HIV IN also can carry out the
disintegration reaction, in which a substrate that mimics one end of the viral DNAjoined
to the target DNA is cleaved into its viral and target DNA parts [5, 6]. The disintegration
reacfion is the reverse of the strand transfer reaction. There is no evidence that
disintegration is biologically relevant in vivo but it is a useful assay to test the
ability of IN to catalyze polynucleotidyl transfer reactions (fig. 1.2).
The homooligomeric HIV-1 IN protein is 288 amino acids in length. Structural
studies, amino acid sequence alignments, limited proteolysis, site-directed mutagenesis
studies and complementation experiments [9-13] have revealed the presence of three
distinct domains per monomer: the N-terminal domain, the catalytic core domain, and
the C-terminal domain. Each domain can independently fold within each monomer. The
first two domains are structurally highly conserved among retroviral and retrotransposon
INs. The N-terminal domain (1-50) binds zinc, the core domain (50-212) contains the
catalytic triad motif (D, D, 35E), and the C-terminal domain (213-288), binds DNA
non-specifically (Fig.3). Insolubility of full-length HW-1 IN has limited structural
analyses to individual domains or two contiguous domains.
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fIGURE 1.1. Overview of the retroviral life cycle. Attachment of the viral envelope
surface protein to specific receptors on the surface of a host cell resuits in fusion and
release of the viral core into the host cell cytoplasm. Reverse transcription then
generates a double stranded DNA copy of the RNA genome. The viral DNA undergoes
3’-processing in the cytoplasm and subsequently travels into the nucleus, where strand
transfer results in the integration of the viral DNA into the host genome to form the
provirus. Transcription generates messenger RNAs as well as viron RNAs. mRNAs are
translated in the cytoplasm. Virus proteins and progeny RNA assemble and bud off at the
plasma membrane and subsequently mature into infectious particles.
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FIGURE 1.2. Schematic representation of the 32P-labelled substrates and products of in
vitro analysis of the enzymatic activities catalyzed by the retroviral IN for a single U5
end. Step 1: 3’-processing; step 2: strand transfer; and step 3: disintegration, which is the
reverse of the strand-transfer reaction.
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FIGURE 1.3. A schematic model ofHIV-1 IN. It shows the tbree independently folding
domains: the N-terminal domain, the catalytic core and the C-terminal domain. The
conserved and catalytically active residues are indicated and the corresponding residue
numbers are shown above each residue. Adapted from FIGURE 10.1 of Asante-Appiah
and Skalka, 1999 [14].
The structures of individual domain structures have been determined by X-ray
diffraction [15-23] or by solution NMR [24-28]. Structures of two contiguous domains,
both the N-terminal domain plus the core domain [13] and the core domain plus the
C-terminal domain [12, 29, 30] have also been resolved. Both individual domain and
two-domain structures are also available for several other retroviral lNs, which are
structurally very similar to HW- 1 lNs. However, there is presently no structure available
for any IN complexed with DNA substrate. In the absence ofthis information, molecular
modeling studies and mutational studies, such as the one presented here, constitute an
alternative method to obtain structure-function information on this pharmacologically
important enze.
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71.1.1 Structure of the catalytic core domain
The catalytic core domain of HW IN is well conserved among retrovirai
INs,shares significant structural simiiarity with the transposase proteins and contains the
characteristic D, D (35) E motif found in polynucleotidyl transferases [26, 28, 31]. These
invariant residues, Asp-64, Asp-116, and Glu-152, are key residues of the active site.
Mutagenesis studies show that substitution of any of the three catalytic residues
abolishes ail three reactions [10, 11, 32, 33]. The core domain alone can carry out the
disintegration reaction [10, 11, 34-36]. However, truncated IN proteins lacking either the
N-terminai domain or the C-terminal domain cannot catalyze 3’ processing and strand
transfer t33, 34, 36-39]. Anumber of structures ofthe catalytic core domain ofHIV-1 IN
exist [12, 13, 15-18, 21, 40]. The overail topology of ail these structures is similar to the
structure in (fig. 1.4). It is roughiy spherical in shape and two core domains associate in
the crystal to form a two-foid axis-reiated dimer. The dimer interface is quite large with
approximately 1300 À2 per monomer excluded from solvent. The interface is quite
hydrophobic and the primary contacts between subunits in both structures involve
a-helices 1 and 5. As the corresponding helices are not involved in protein—protein
contacts in the Tn5 transposase-DNA compiex, which has been recentiy resolved [41],
and as the DNA plays an important roie in Tn5 transposase dimerization, one might
argue against the bioiogicai relevance of this interface. However, functionai IN has been
suggested to be active as a tetramer [14, 42] or even an octamer [43]. This crystaiiized
IN dimer and its interface may act as a whoie to bind the same virai end and function as
the single Tn5 transposase monomer does.
7
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FIGURE 1.4. Stmcture ofthe catalytic core domain ofHIV-1 integrase. Corresponding
13-strands and a-helices are labeled in panel A, Side chains of consewed acidic residues of
the active site are shown in a bail and stick representation in panel B. Coordinates ftom a
HW-1 IN core domain (accession codes 111G in the Brookhaven Protein Data Bank) was
used to generate this Figure; middle panels were created using published coordinates.
Each monomer consists of a five-stranded 13-sheet together with six Œ-helices.
The three catalytic residues of the core domain are Ïocated in close proximity in the
structure and define the position of the active site (Fig. 1.4). However, the two
catalytic sites are on opposite sides of the spherical,crystal dimer and are separated
by approximateiy 30À. On the other hand, the integration sites on target DNA are
generally separated by 5 bp, which is equivalent to roughly 15 Â in B-form DNA.
Thus, the distance observed in the dimer structure is not compatible with catalysis
of the integration event. Either this crystal dimer structure is not biologically relevant
or else higher order multimers are formed in vivo based on the dimer structure, such that
two active sites could be positioned doser in a higher order muitimer [15].
8
91.1.2 Structure of the N-Terminal Domain
The crystal structure of the N-terminal domain reveals a dimeric structure.
Conserved residues His 12, Ris 16, Cys 40 and Cys 43, located in a three-helix bundie,
ensure tetrahedral coordination of Zn2. At the monomer level, the structure of the
N-terminal domain determined by X-ray diffraction as part of the N-terminal domain
plus core structure is very similar to the previously determined NMR structure of the
isolated N-terminal domain. However, the dimer interface is entirely different (Fig. 1.5)
[13]. Whereas it is dominated by interactions between the third helix in the NMR
structure, the dimeric interface in the 1—2I2 crystal structure (N-terminal domain plus
core) comprises the N-termini of the first and third -he1ix. The surface of the dimer
interface in the two-domain structure is smaller and more hydrophobic than in the dimer
ofthe isolated domain in solution.
The biological relevance of Zn2 and the N-terminal HHCC domain in HW IN
has been well documented. Indeed, utilizing a combination of techniques including UV
visible absorption, circular dichroism, and fluorescence spectroscopies, it has been
demonstrated that metal ions (Zn2, Co2, or Cd2) are bound with equimolar
stoichiometry by the isolated N-terminal domain t44]. A mutation in the HHCC motif
abolishes zinc-binding capacity of HIV-1 iN. The isolated N-terminal domain is
disordered in the absence of zinc [45]. The N-terminal domain is necessary for
3’-processing and strand transfer activity in HIV-1: deletion of this domain or mutation
of any of the four conserved HHCC residues abolishes 3’-processing and strand transfer
activity ofHW-1 iN [10].
However, in a study of RSV IN, 3’-processing and strand transfer products are
detectable in reactions after deletion of the HHCC domain, but is much less efficient
9
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than with the wild type in the presence of Mn2 but flot Mg2. Most strikingly, when a
mutant of RSV IN lacking the N-terminal HHCC domain is fused to various short
peptides, efficient strand transfer activity can be restored to the level of wild type RSV
IN [46]. Similarly, deletion of this domain in Visna virus [47] IN has no effect on
3’-processing. Substitution of Hisl2 and Hisl6 in RSV IN does not significantly impair
3’-processing or strand transfer [48]. When the N-terminal domain of IN expressed
independently, it does flot bind DNA [9, 48], but it has been suggested that it interacts
with DNA in the context of the intact protein t48-51]. Furthermore, several studies
showed that Zn2 promotes multimerization, which should thus occur through the HHCC
motif and enhances the catalytic activity of HIV-l IN [45, 52], however, mutants lacking
this domain can stiil form tetramers [53, 54]. Based on the above observations; the exact
role of the N-terminal domain in these reactions is not clear. However, the high
conservation of this motif and resuits from genetic experiments suggest that this domain
is functionally important. Further biochemical studies are needed to conclude on its in
vivo importance.
10
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FIGURE 1.5. Ribbon drawings of N-terminal domain structures. Side chains of
conserved HHCC residues of the Zn2-che1ating HHCC motif are shown in a bail and
stick representation. The Zn2 cation is shown as CKP. The N-terminus and C-terminus
are indicated. (A) and (B) Coordinates from PDB file 1 WJA determined by NMR; (A)
shows the monomer and (B) the dimer. (C) The dimer interface is shown for the
N-terminal domain from PBD file 1K6Y determined by X-ray diffraction. Note that the
dimerization interface in this crystal structure is completely different from the solution
structure in (B).
11
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1.1.3 Structure of the C-Terminal Domain
The amino acid sequences of the C-terminal domain, which are approximately 80—100
amino acids long, are flot conserved among INs from different retroviruses. Mutation
and deletion analyses with both avian sarcoma virus (ASV) and HW-1 INs indicate that
the C-terminal domain contains nonspecific DNA binding activity [9, 48, 55-57]. With
the exception of Feline Immunodeficiency Virus (fIV) N [23] in which deletion of the
C-terminus (residues 236-28 1) resulted in a mutant that retained efficient 3’-end
processing and disintegration activities but weak 3’-end joining activity, ail lNs with a
deleted C-terminal domain lose 3’ processing and strand transfer activities [11, 34, 36,
39, 46, 58-60]. This inability presumably resuits from loss of capacity to correctly
position and orient the viral LTR ends at the active site. However, when the viral DNA
ends have been correctly prepositioned, such as with a synthetic disintegration substrate
during in vitro assays, catalysis can occur with mutant Ns that have been truncated at
the N-terminus or the C-terminus or both [36, 54]
Two studies using NMR [24, 61] on solutions of HW-1 IN C-terminal domain
showed homo-dimeric structures with each subunit composed of a five-stranded 3
-barrel that is topoiogically very similar to structures of SH3 domains, which occur
in many signal transduction proteins [11, 46, 60, 62, 63]. These two solution structures
agree well with each other (Fig. 1.6). The structure of the C-terminal domain monomer
resolved by X-ray diffraction is also similar to the structures resolved by NMR. The two
C-terminal subunits in the dimeric structure are related to each other by a 90° rotation
relative to their two-fold axis.
Structures also exist for the N-terminal domain plus the core domain [13] and for
12
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the core domain plus the C-terminal domain [12, 29, 30]. The core domains in those two
domain structures are almost identical to the structure of the isolated core domain and
the two-fold symmetrical dimer interface is also similar. Superimposition of the catalytic
core of these two-domain structures resuits in a proposed structure of the full-length IN
dimer, which might be biologically relevant [13] and will be fùrther discussed in this
thesis. Residues 271—28$ in the C-terminal domain are either not clearly resolved or
deleted. The hinge region connecting the core and the C-terminal domain is different
among HIV-1, Simian immunodeficiency virus (SIV) and Rous sarcoma virus (RSV) IN,
which probably reflects flexibility in this region. Moloney murine leukemia virus
(M-MULV) IN contains a sequence insertion ofunknown function in this region [64].
The interactions at the dimer interface are predominantly hydrophobic and
localize to 3-strands 2, 3, and 4 , with the two triple-stranded antiparallel 3-sheets, one
from each subunit, oriented antiparallel to each other. One surface of the dimer is a
saddle-shaped groove with dimensions ofapproximately 24 x 23 x 12 À in cross section,
which could accommodate a duplex DNA molecule [24]. This groove contains basic
residues favorably positioned to contact DNA. Lys264, which has been shown from
mutational data to be involved in DNA binding, protrudes from this surface. The
diversity and hydrophobic character of the protein—protein interactions forming dimer of
the C-terminal domains from HW-1, RSV [30], and SP/ [29] suggest that they are weak
and nonspecific [12].
13
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A B
FIGURE 1.6. Ribbon drawings of C-terminal domain structures shown in monomeric
form. Coordinates from PDB file 1MV determined by NMR was used to generate (A).
Coordinates from PDB file 1EX4 determined by X-ray diffraction was used to generate
(B).
1.1.4 Integrase-DNA interaction
There are currently no IN structures available with substrate DNA docked in the
active site. However, available IN structures and biochemical data provide considerable
information about IN-DNA interaction. This section provides a review of the
information available to date, which will be used as a basis for interpretation of the
results presented in this thesis.
In the preintegration complex, IN must make specific interactions with viral DNA
sequences, and afler transporting the preintegration complex into the nucleus, IN must
also interact with the target DNA for the integration reaction to occur. It is clear that IN
can distinguish between viral DNA ends and other oligonucleotides [65-6$] since IN
protein requires both the subterminal and the distal position of its viral DNA recognition
14
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sequence for efficient cleavage to occur; however ultraviolet (UV) cross-linking
studies [55, 69], filter binding assays [37, 70], Southwestern blots [56, 59], and
electrophoretic mobility shift assays [51] show that IN binds to substrate DNAs
with affinities similar to those of nonsubstrate DNAs in vitro. In other words,
although the 3’ processing and strand transfer activities of retroviral IN are
sequence-dependent on both the distal and proximal sequences [67, 71-75], the
binding of iN to DNA seems nonspecific. [55, 76, 77]. Experiments suggest that
specificity in catalysis is achieved by nucleotides both distal and proximal to the
conserved CA [74, 75] and metal cofactor t77-80]. for example, experiments
showed that a stable complex of IN and viral DNA is formed in the presence of Mn2
and the IN-viral DNA complex is resistant to challenge by an excess of competitor DNA
[78]. A comparative study shows that each iN from M-MUL’vÇ human T-cell leukemia
virus (HTLV)-l, HTLV-2 and HIV-1 required specific terminal LTR sequences for
optimal catalysis of 3’-processing reactions, while strand transfer and disintegration
reactions do not. Furthermore, in the 3’-processing reaction, sequence specificity for
each IN was traced to the three nucleotides proximal to the conserved CA [81] in the
presence of metal Mn2. Another study, by in vitro selection and specific
photocrosslinking in the presence of Mg2, identified that distal positions in the LTR
termini interact with the C-terminal domain of IN, providing evidence for the role of that
domain in stabilization of viral DNA binding, while the terminal LTR interaction is
mapped to the disordered loop of the iN core domain, specifically residues Q148 and
Y143 t82]. Integrases need to fray viral LTR double-stranded DNA ends for
3’-processing to proceed since adding nucleotides to the 3’-end of the LTR sequence
severely reduces 3’ processing while increased cleavage by IN was detected when the
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nucleotides 3’ to the CA-3’ dinucleotide were present as single-stranded DNA [66].
Further evidence cornes from a nucleotide analog substitution study, in which
substitutions increasing the hydrogen bonding between the ‘plus’ and the ‘minus’ strand
decreases 3’ processing activity, while those which reduce or disrupt base pairing in the
conserved CA dinucleotide increase activity [76, 79, 83-87]. This requirernent for
base-pair disruption may account for the inability of iN to use intemal sites on DNA
molecules as viral att (attachment) sites. Binding of IN to U5 LTR DNA is tighter,
exhibiting a prolonged half-life in the presence of Mn2 cations compared to Mg2. The
preference observed for Mn2 in standard in vitro integration assays can be attributed
entirely to the augmentation in the DNAbinding affinity ofthe IN [77].
The core dornain contains the active site and is the only part of the IN protein
capable of independent nucleotidyl transfer. This dornain interacts with viral LTR ends
[43, 67, 71, 72, 76, 79, 82, 88-90]. for example, cross-linking data have demonstrated
that conserved Lys156 and Lys159 residues are involved in binding ofthe adenosine
ofthe conserved CA [71]. Furthermore, three active site residues ofthe DD35E motif in
the core must contact both the viral LTR end and the target DNA for the integration
reaction to occur. Cross-linking experiments also suggest that the adjacent conserved
cytosine and the 5’ dinucleotide on the noncleaved strand also make contact with
regions of the core domain, in and around the flexible ioop [$2, $8]. These data
support a clear role in viral DNA end binding by the core domain. However, IN is
known to function as a multimer (see section 1.1.5), and it remains to be determined
which specific DNA contacts are in cis or trans with respect to the active site.
The N-terminal domain is in close proxirnity to target DNA 5’ to the site of
integration as shown by crosslinking data [88]. By constmcting chimeras between HW-1
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and Visna virus iNs, it is suggested that the N-terminus of IN does flot contribute to viral
DNA specificity and is flot involved in determining substrate specificity for
3’-processing and strand transfer activities. Thus, this function must reside in the central
region or C-terminus of IN [47]. Furthermore, the first 26 residues of RSV and HIV-1
IN, which include the first two histidines in the HHCC motif, are flot required for DNA
binding [9, 76].
Experiments showed that the C-terminal domain of IN interacts with bases distal
to the terminal bases of the LTRs [71, 82, 88]; this interaction may play an important
role in stabilization of viral DNA binding t82]. This may help to explain several
results in which mutations in the C-terminal domain affect the 3’-processing
activity [57, 91], which does not require the binding of target DNA. Structurally, it
is suggested that a strip of positively charged amino acids from both monomers
extending from each active site of the dimer to the C-terminal domain of the other
monomer may act as dimeric platform for binding each viral DNA end. This strip
potentially may stabilize the viral att site DNA for 3’-processing and strand transfer. This
putative DNA binding site involves residues from both monomers: the core from
monomer A with the C-terminal domain from monomer B in the dimer implying that a
viral end cleaved in the active site of one monomer is stabilized by residues from the
C-terminus of the other monomer This is consistent with in vitro complementation
experiments [11, 39]. Previously, the C-terminal domain has been presumed to be
involved in target DNA binding and this IN-target DNA interaction has been
presumed to be nonspecific [57, 91], which is suggested by target sites ofintegration
known to exhibit very little sequence specificity [92, 93]. Mutation of conserved
lysine-264 has a dramatic effect on the nonspecific DNA binding activity of the
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isolated C-terminal fragment, as judged by ultraviolet (LTV) cross-linking, and by
3’-processing by full-length N containing a K264E mutation [24, 57]. Structural
modeling based on NMR C-terminal structure, discussed in section 1.1.3, illustrates
that the dimensions of the saddle-shaped groove consisting of amino acids 220-270 in
the dimer are appropriate for DNA binding. In this model, amino acids 220-270 in the
dimer can readiÏy bind to the major groove of DNA, where the side-chains of Ser230,
Pro261, Lys25$, and Lys264 interact with the sugar-phosphate backbone, and the side
chain of Arg231 interacts with the bases [91]. Some work has suggested a role for
Arg-262 and Leu-234 in DNA binding [91]. Mutagenic analysis shows that Ser-230
and Arg-263 are involved in enzymatic activity and DNA binding [91]. Although the
C-terminal domain has been implicated in binding of target DNA, certain work from
chimeric N proteins shows that the core domain plays a more important role in target
binding than the N- or C-terminal domains [47, 58]. Activity assays show that these
chimeras exhibit the target site preference of the core domain, but flot ftanking
domains. Some cross-linking experiments have crosslinked target DNA to portions
of both the core and C-terminal domains, as well as a region of the N-terminal
domain [94]. The exact function of the C-terminal domain is stiil not quite clear,
but available experimental data suggest the idea of a complex network of DNA
binding rather than a model in which individual domains are unilaterally
responsible for binding to viral or target DNA [42]. Transposases and retroviral INs
share a structurally related catalytic domain. They are members of the larger superfamily
ofpolynucleotidyl transferases. Homology modeling based Tn5-DNA complex structure
is likely to give us insights about N-DNA interactions.
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1.1.5 Multimeric organization ofHIV-1 IN
Many evidences show that IN functions as a multirner. However, there is
conflicting evidence with respect to the number of units composing the active
multimer and with respect to the actual dimerization interfaces. Clearly,
identification of the multirnerization interfaces must take into account the surfaces
involved in DNA binding, and vice-versa. In the absence of structural data of
multimers with bound DNA, our study set out to explore these potential binding
surfaces using biochernical rnethods. The following section describes the
information available to date, which will be used as a complement for interpretation of
the resuits presented in this thesis.
Biochemical studies have revealed that multimerization determinants reside in
the core domain, as well as in the N-terminal and C-terminal regions of HIV- 1 IN [95].
Deletion mutants ofHIV-1 IN that lack either the N-terminal or C-terminal domain
have no 3’-processing or strand transfer activity [34]. However, if an N-terminally
truncated IN is mixed with a C-terminally truncated IN, 3’-processing and strand
transfer activities can be restored [34] [11]. Further evidences for multirnerization
corne from mutagenesis and deletion studies which show that full-length N can
multirnerize to form both dirners and tetramers in solution [45, 52, 96, 971.
Furthermore, the N-terminal domain of IN can function in trans but flot cis to the core
domain [32, 9$], while the C-terminal dornain can function in cis [34] or trans [11, 34,
43, $9].The above results also suggest that the core domain contributes the active site
enzymatic activity in partnership with an N-terminal domain from a different monomer
of iN.
The difficulty of deterrnining the multimeric organization of HIV-1 IN
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cornes frorn the fact that purified recombinant INs can exist in a dynarnic
equilibrium including monorners, dirners, tetrarners, and even higher order
oligomers [50, 96, 99-101], and any species can be an active form of IN except the
monorner [96]. The stoichiometry of retroviral IN complex is flot known in vitro.
Several structural studies show that a tetramer (dimer-of-dimers) or an octamer of IN
wouldbe necessary to carry out concerted ifitegration ofboth LTRs on target DNA [13,
30, 43]. for example, the overail structure of an IN tetrarner formed by crystal lattice
contacts frorn the N-terminal and core two-dornain structure ti 3]is structurally similar to
a related bacterial transposase Tn5 dirner cornplex with its DNA substrate, which can be
considered as evidence supporting the 51V tetrarneric model. Furthermore, this tetrarner
model exhibits positively charged channels suitable for DNA binding [13]. A recent
study that used iN complexes present in nuclear extracts from human cells suggested
that the minimal cellular IN cornplex is a homotetramer, implying that at least an
octamer of iN is required to carry out concerted integration of both LTR ends into target
DNA [102]. Within this tetramer, it will be only one ofthe two active sites in each dimer
that would be actually involved in the chemical reactions.
1.2 Purpose and Scope of the Study
1.2.1 Research objectives
The integration process is an obligate part of the retroviral life cycle. Retroviral iN
is both essential and sufficient to catalyze this integration reaction. The overail aim of
this study is to gain a finer understanding of the biochernistry of the integration reaction.
The specific research objectives ofthis dissertation include:
The expression, purification and characterization of the previously obtained
insertional mutants ofHIV-1 IN.
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• To gain insights into the role ofpreviously predicted unstructured loops.
• To map functionally tolerant region of insertions ofHIV-1 IN.
• To gain insights into IN-DNA interaction.
• To compare available tetramer models with our experimental data to see how
they agree with our new data and with existing biochemical data.
• b define domain boundaries, which might be useful to express minimized IN
constructs for crystallization studies.
1.2.2 Significance of the study
The development of effective inhibitors of HP! replication targeted to HP!
reverse transcriptase and HIV protease has demonstrated the potential effectiveness of
antiviral therapy for the treatment of ATDS, which benefits from the foundation of basic
knowledge in understanding the mechanism of retroviral reverse transcription and the
structure of the protease. Drugs targeted to HP! IN would be a valuable complement to
reverse transcriptase and protease inhibitors. However, the lack of detailed structural
information about IN/substrate interactions has so far hindered the search for strong and
selective IN inhibitors. Although the structures of ail three domains of IN have been
individually determined, their spatial arrangement in the active complex with DNA
substrate is unknown. The studies I present herein using a linker-scanning approach will
provide a better insight into the functioning of this enzyme. Resuits from this study will
therefore provide valuable information for those concemed with the design of effective
inhibitors of the retroviral IN.
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Chapter H
Compreliensive Linker-scanning Analysis of
tlie 111V-1 Integrase Protein
2.1 Context of the work relative to resuits obtained previously
The work described in Chapter 2 was begun prior to registering as a M.Sc. student
in the Bio-informatics program at Université de Montréal. Specifically, Sections 2.2.2:
Mutagenesis: In vitro transposon-based linker insertion into pLNSD+Iis; 2.2.3: Selection
of clones with insertions within the HW-11N coding region; and 2.2.4: Generating the
IN frame 19-codon insertion, were performed by myseif while I was a research associate
in the laboratory of Prof. C. Jonsson, currently at the Southern Research Institute,
Department of Biochemistry and Molecular Biology, Birmingham AL. As this work is
not yet published, it is described herein in full, with the approval of Prof Jonsson.
Sections 2.2.5: Expression and purification of mutant and wild-type IN; 2.2.6: Substrate
preparation; and 2.2.7: In vitro integration and disintegration assays, were initiated prior
to registering as a M.Sc. student and were completed during the course of this degree.
Section 2.2.8: Structural model of HIV-1 IN monomer were initiated and completed
during the course of this degree.
The work presented in Chapter 2 has been submitted as part of a collaborative
manuscript entitled: Comprehensive Linker-Scanning Analysis of the MuLV RNase H,
MuLV and HIV-1 Integrase Proteins, Author: Jennifer Puglia1, Tan Wang2, Christine
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Smith-Snyder’, Marie Cote’, Michael Scier’, Joelle Pelletier4, Sinu John3, Colleen B.
Jonsson2 and Monica J. Roth’
‘Department of Biochemistry, Robert Wood Johnson Medical School, University of
Medicine and Dentistry ofNew Jersey 675 Hoes Lane Piscataway, NI 08854.
2 Department of Biochemistry and Molecular Biology, Southem Research Institute,
2000 9th Ave S, Birmingham, AL 35205.
3Graduate Program in Biochemistry and Molecular Genetics, University of Alabama at
Birmingham, Birmingham, AL 35294.
4Département de Chimie, Faculté des Arts et Sciences, et Département de Biochimie,
Faculté de Médecine, Université de Montréal, C.P. 6128, Succursale Centre-Ville,
Montréal, Québec H3C 317, Canada
2.2 Introduction
Various methods have been developed for the comprehensive analysis of a gene
by construction of a saturating or near-saturating library of mutants t103-105]. These
studies have defined domain boundaries, provided functional maps, and insights into
previously predicted unstructured loops [106] [103-105, 107-109]. In this study, the
method ofinsertional functional mapping is applied to the HW-1 IN (iN) protein.
The integration of retroviral particles is a complex process. Preintegrative
complexes (PICs) lias been purified and characterized from infected cells [110-122].
Despite extensive study, the assembly of this complex is flot well understood. These
efforts have been assisted by structural studies ofrelated retroviral iN subdomains [12,
13, 16, 19, 26, 29, 30, 123, 124]. However, to date, neither a structure of a complete
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retroviral IN protein nor one of a subdomain in complex with DNA has been obtained.
The linker-insertion genetic footprint provides a means to identify non-essential
regions within proteins capable of withstanding insertions. Ibis method relies on
retroviral-mediated insertion of a specific DNA sequence at various, random locations
within target DNA. The insertion of a large DNA fragment is followed by excision of
part of - but flot ail — the inserted sequence, leaving a shorter (57 base pairs), specific
DNA sequence within the target gene. Upon expression, the inserted fragment is
translated within the target protein, resulting in disruption of the native sequence.
Disruption of function indicates that the area of insertion does not tolerate structural
disruption, for any of a variety of reasons: the disrupted area may be directly required
for function, may be required for oligomerization or may be essential to the folding of
the target protein.
In this study, the HIV-1 IN gene was subjected to Tn5-based random insertion
mutagenesis. Individual constructs, selected from the library, were assayed for the
effects on in vitro iN enzymatic activity assays. The observed activities of the resulting
iN mutants provide insights into the possible roles of the various parts of the HW- 1 iN
protein. Using this approach, three regions that are functionally tolerant of insertions
were identified within iN. These regions correlate with domain and protein junctions.
2.3 Experimental Procedures
2.3.1 Materia]s
Oligonuleotide PCR primers and oligonuleotide substrates were synthesized by
Integrated DNA Technologies (Coralville, Iowa). Restriction enzymes, Taq polymerase,
14 DNA ligase and kinase were purchased from New England Biolabs (Beverly, Mass.).
The EZ: TN In Frame Linker Insertion Kit was purchased from EPICENTRE (Madison,
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WI). Ail chemicals were purchased from Sigma.
Bacteriai Strain and Plasmid: Plasmid pINSDHis containing HIV-1 IN was
obtained from the ADS Research and Reference Reagent Program. It was used to
construct HW- lIN mutants and was propagated in Escherichia cou strain DH5Œ. E cou
strain BL21 (DE3) was used to express wild type HW-l IN and its mutants.
2.3.2 Mutagenesis: In vitro transposon-based linker insertion into pINSDHis
The EZ: IN In Frame Linker Insertion Kit was used to insert a nucleotide linker
at random into the target piasmid pINSDHis, as described in FIGURE 2.1. The reaction
mixture contained 1 jil EZ::IN lOx reaction buffer, 0.4 ig pINSD±Iis piasmid DNA,
1tl (0.1pmol/il) EZ::TN<Not/KAN-3>Transposon, liii EZ::TN Transposase in a final
volume of 10tl. The reaction mixture was incubated for 2 hours at 37 oc and the
reaction was stopped by adding 1 111 EZ::TN 10x Stop Solution. 1 tl — 10 al of the
insertion reaction mixture was used to transform MAX Efficiency E. cou DH5Œ
Competent Ceils from Invitrogen (Carlsbad, CA) and piated and selected on
kanamycin-containing plates by ovemight growth at 37°C. Each individual colony was
picked and transferred into 96 well culture blocks from Qiagen (Valencia, CA) with imi
LB containing 50tg!mi kanamycin in each well. Afler ovemight growth at 37 oc with
shaking, 50% glycerol was added to each well to bring the final concentration of
glycerol to 10% and the blocks were stored at —80 °C.
2.3.3 Selection of clones with insertions within the 111V-lIN coding region
The <Not IIKAN-3>Transposon shouid be randomly inserted into the target
DNA plasmid pINSD±Iis. A PCR strategy was employed to determine whether the
transposon insertion sites were within the HW-1 IN coding region and their distribution.
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The pinsdBsreen primer (5’-CGG GCT TTG TTA GCA GCC GG -3’) and pinsdFscreen
primer (5’-GGT GCC GCG CGG CAG CC -3’) were used to amplify the iN and
encoding sequence from 301 to 320 and 335 to 351 of the pETl5b plasmid, which is
parent plasmid of p1NSD. The PCR reactions contain 1xPCR buffer of ExpandTM long
Template PCR system from Boebringer Mamiheim (Gmbh, Germany), 2.25mM MgSO4,
0.2mIVI dNTP, 2 iM primers, 2 units Taq polymerase and traces of the glycerol stocks
stored at-80 OC .The reactions were carried out in 96 well PCR plates from Robbins
Scientific Corporation (Suuyval, CA). PCR conditions were as follow: 94 °C for 4
minutes, followed by 35 cycles of: denaturing at 94 oc for 30 seconds, annealing at 69
°C for 30 seconds followed by an extension step at 72 oc for 2minutes and 15 seconds.
This cycle was followed by a final extension period at 72 oc for 4 minutes, which was
followed by a hold at 4 °C. Afler PER, the samples were loaded onto a 1.5 % agarose
gel and examined to determine which of the clones are positive for linker insertion
within the IN gene.
2.3.4 Generatïng the IN frame 19-codon insertion
The clones with a transposon insertion site within the IN coding region were
individually digested with NotI according to manufacturer’s recommendations.
Purification of the linearized DNA from the 1100 bp kanamycin—containing fragment
was carried out by agarose gel electrophoresis. Religation of the linearized DNA by T4
DNA Ligase regenerated a single Not I restriction site and created the 57 nucleotide (19
codon) insertion into any of the three reading frames (Fig. 2.1). The religated DNA was
transformed into E. cou DH5Œ cells and selection was done on Kanamycin-containing
plates. DNA sequencing of transposon insertion clones was performed with the ABI
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® TM ®PRISM BigDye Pnmer v3.0 Cycle Sequencing Ready Reaction Kit with AmphTaq
DNA Polymerase, FS. (Foster City, CA) to determine the site of the 19-codon insertion.
The integrated sequence analysis software VectorNTl from InforMax Inc. (Frederick,
MD) was used to analyze the sequence data.
2.3.5 Expression and purification of mutant and wild-type IN
Wild-type HIV- 1 IN and insertion mutants were expressed in E. cou BL2 1
(DE3) celis in 50 ml ofmedium and purified as hexahistidine-tagged fusion proteins
under denaturing conditions as described previously [83]. 50 ml cultures purification
yielded approximately 2 mg of 90—95% homogenous protein (Fig. 2.3). The protein
fraction refolded at a concentration of 5 mg/ml exhibited greatest enzymatic activity.
HPI-1 iN precipitated upon addition of Buffer C (0.2 M NaC1). The precipitated
protein was re-suspended in Buffer D (0.5 M NaC1) to a final concentration of 1
mg!ml.
2.3.6 Substrate preparation for in vitro activity assays
Oligonucleotides were purified on 20% denaturing polyacrylamide gels,
32P-labeled at the 5’ end with 14 polynucleotide kinase, and hybridized to
complementary strands as previously described (Jonsson et al., 1993). Unincorporated
radioactivity was removed from labeled integration and disintegration substrates with
G-25 or G-50 Quick Spin columns (Boehringer, Manriheim, iN).
2.3.7 In vitro integration and disintegration assays
Strand transfer and disintegration reactions were performed as described
previously [83]. Reaction products were separated on 20% polyacrylamide denaturing
gel and subjected to autoradiography or Phosphorimager screens (Molecular Dynamics).
Products were quantified with ImageQuant software (Molecular Dynamics).
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2.3.8 Structural model of 111V-1 IN monomer. The structural mode! of the HW- 1 IN
monomer was constructed from a combination of two X-ray crystal structures,
represented by PDB files lk6y and lex4. The “A” molecule of lk6y was superimposed
onto the “A” molecule of 1e4 using the program O. The lky structure is comprised of
residues 1-46, 56-139, and 149-210; and lex4 is comprised of residues 56-141 and
145-270. Thus, the superpositioning consisted of overlaying the CŒ atoms of ail
common core residues (RMSD-0.83 angstroms). Where the mode! contained disordered
regions (residues 47-55 and 142-144, inclusively), poiyalanine segments containing the
correct number of amino acids were created and moved into the appropriate linking
positions in the mode!. The Ala residues were then changed to the proper residues, and
the regions were subjected to ieast squares minimization.
2.4 RESULTS
fig. 2.1 outiines the series of steps undertaken to generate the linker-insertion
iibrary within the HW-1 IN construct pINSDHis. Briefly, the Tn5 mutagenesis system
resuits in the random insertion of the transposon encoding the kanamycin resistance
gene throughout the plasmid. To make the screening process high throughput, each
individual coiony was picked and transferred into 96 weiis culture blocks. km total, 1056
colonies were picked into 96 well culture blocks to screen mutants with a transposon
inserted into the N coding region by PCR. Any insertion within the IN will be amplified
to a 2.1 kb product while an insertion within the vector sequence will amplified to a
0.9kb product. Each clone with a transposon inserted into the IN coding region was
digested with NotI and religated to create the 57 nucleotide (19 codon) insertion. The
amino acid sequence of the HW- 1 IN encoded by the target DNA pINSD is conserved
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on both sides of the 19-codon insertion. These constructs with 19 amino acid insertions
were transformed into E. cou and selected using the ampicillin-resistance gene
(t3-lactamase) that is present on the original cloning vector. Selected insertion mutant
proteins were expressed and purified. Strands transfer activity and disintegration activity
were performed on these purified insertion mutants to evaluate the effect of insertions in
different sites. The resuits obtained in each step ofthe procedure are described below.
2.4.1 Selection of clones with insertions within the HIV-1IN coding region by
PCR
To determine the transposon insertion sites, PCR was used to screen the clones
that have a transposon inserted into the HW-1 iN coding region. As shown in Fig. 2.2,
insertion within IN coding region resulted in a 2100 bp PCR product; otherwise a 910 bp
PCR product was obtained. 0f 1056 colonies (11 x 96 well plates) screened, 111 of them
were positive for having one insertion within the IN gene. The 57-base pair insertion
generated by the Tn5 In-Frame Linker Insertion scanning system resulted in insertions
into all three reading frames of the original clone. Nine of the 57 nucleotides are the
result of a 9 bp sequence duplication immediately ftanking the transposon insertion site.
The amino acid sequence of the protein encoded by the target DNA is conserved on both
sides of the 19 codon insertion. Sequencing from the library (Table 1) showed that
insertions were distributed throughout the whole IN encoding region. The insertion sites,
however, were not randomly distributed, with clustering of insertions within the
C-terminal domain. This could indicate a preference for specific structure within the
plasmid DNA by the transposase enzyme since a large number of duplicate isolates were
identified within the population examined. The composition of 19-amino acids inserted
are determined by the target site selected and two 9 bp target site sequence duplication
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during the transposition as well as the sequences encoding the NotI restriction site and
two 1 9-bp inverted repeat mosaic end sequences, which are recognized by Tn5
transposase. Depending on the reading-frame, the insertions will encode
XCLLYTSCGRKMCTRD(S/R)XX, LSLVHILRPQDVYKRQXXX or
XVSCTHLAAARCVQETXXX.
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HIV-1 IN
pINSD
+
NotI NotI
4
Kant
EZ: TN transposon
4 Transposase
Transform and selection ofE.coh for Kan® (2x1 Q3 colonies)
PCR to identify the individuel clones with insertions
are within IN encoding region.
li
Digest with NotI, religateto generate 19 codon
insertion, transformE.coh.
4
Expression mutated protein, assay for disintegration
and strand trans fer activity
FIGURE 2.1. Generation of the HIV-1 insertional library. The three steps required to
generate the insertional library within the construct are outlined. The region of IN gene
encoding the Integrase (IN) protein subjected to TN5 insertional mutagenesis and
transposon Tn5 DNA, which contained the kanamycin resistance gene between its short
19 basepair Mosaic End (ME) Tn5 transposase recognition sequences, are shown.
Restriction sites Not I flanked by the ME also are shown.
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N coding region. A 2100-bp band indicates the presence of one single insertion within
the IN coding region. A 91 O-bp product indicates the presence of an insertion within the
vector pINSD but outside of the IN coding region.
2.4.2 Insertion Sites of HIV-l Individual mutants
The final insertion library for HW-1 N was characterized by analyzing individual
isolates. Isolates of the final library were subjected to sequencing analysis. 0f the 111
insertions, 2 were within the N-terminal domain, 35 were within the catalytic core and
74 within the C-terminal domain. Afler eliminating the duplicate clones, where
insertions are in the same position with same insertion sequence, 55 clones have unique
insertion positions and correct sequence (summarized in Fig. 2.6. and Table 1). Each
mutant N isolate was transformed into E. cou BL21 (DE3) and each mutant integrase
was purified and further characterized by in vitro enzymatic analysis of individual
clones.
FIGURE 2.2. PCR products in the clones with insertion and without insertion within the
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2.4.3 Expression and purification of the wild type and mutant IN
Fifty-five insertional mutant proteins were expressed, purified and assessed for
strand transfer and disintegration activity (Table 1 and Fig. 2.6). Mutants with a
variety of activity levels were identified in each domain, the N-terminal, core and
C-terminal.
E. cou BL21 (DE3) ceils were used to express wild type IN or the insertion mutant
INs by inducing with WTG. Following the induction period, total protein was extracted
under denaturing conditions. Solubilized protein can be isolated by nickel affinity
chromatography. This one-step affinity purification yielded approximately 2-3 mg of
90—95% homogenous protein from 50 ml of cells, and is well suited for manipulating
multiple purifications in parallel. As can be observed following migration ofthe samples
on 4-12% SDS polyacrylamide gel electrophoresis (PAGE) (Fig. 2.3), HW-1 IN
insertion mutants with the extra 19 amino acids migrated a littie slower than wild type
IN. Column fractions containing the most enriched INs were pooled and diluted to
ascertain the optimal concentration for refolding as measured by the activity of the
HW- 1 IN enzyme. The protein fraction refolded at a concentration of 5 mg/ml exhibited
greatest enzymatic activity. HW-l iN precipitated upon addition of Buffer C (0.2 M
NaC1). The precipitated protein was resuspended in Buffer D (0.5 M NaC1) to a final
concentration of 1 mg!ml.
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Table 1: Summary ofHIV-1 IN insertions
27L
S127L
‘355 C
D55C
P58G
D64_C
173_L
183I
E 96_T
T115D
D116N
T1 25_V
1&12 8A
13iW
113 5K
FJ144P
S147Q
0149V
Vi 65_R
0167 Q
1U69E
E 170_H
K173T
T174A
Ml 7 SA
A196G
1200_V
72010
LSLVHI LRPQDVYKRQDFN
PVSCTHLAAARCVQETDFN
LSLVHI LRPQDVYKRQQVD
CLLYTSCGRKMCTRDRQVD
VSCTHLAAARCVQETDCSP
SVSCTHLAAARCVQETELD
LSLVHILRPQDVYKRQKVI
TVSCTHLAAARCVQETGGY
LSLVHILRPQDVYKRQGQE
CLLYTSCGRKMCTRDRVHT
TVSCTHLAAARCVQETDTD
AVSCTHLAAARCVQETGTT
CLLYTSCGRKMCTRDRVKA
LSLVHILRPQDVYKRQACW
CLLYTSCGRKMCTRDRGI
LSLVHI LRPQDVYKRQPYN
CLLYTSCGRKMCTRDS PQS
AVSCTHLAAARCVQETGQG
LSLVHI LRPQDVYKRQGQV
CLLYTS CGRKMCTRDRVRD
CLLYTSCGRKMCTP]3RDQA
PVS CTHLAAARCVQETEAE
LSLVHI LRPQDVYKRQHLK
CLLYTSCGRKMCTRDSLKT
LSLVHI LRPQDVYKRQVQM
CLLYTS CGRKMCTRDRYSA
CLLYTS CGRKMCTRDRERI
AVSCTHLAAARCVQETGIV
A2 05_T
02071
E2 121
R2 2 BD
S230R
A239K
K240L
W243_K
G245_E
G247A
A2 48_V
V2501
V2501
1251 Q
025 3N
S2 550
V259_V
1268_R
R2 69_D
G272K
K2 73Q
0279 C
V281A
R2840
Q2 85_D
E287D
0288
VSCTHLAAARCVQETDI lA
LSLVHILRPQDVYKRQATD
SVS CTHLAAARCVQETAKE
AVSCTHLMARCVQETDYR
S CLLYTSCGRKNCTRDRDS
TVSCTHLAAARCVQETGPA
PVS CTHLAAARCVQETAAK
NCLLYTSCGRKMCTRDSLW
CLLYTSCGRKMCTRDSWG
LSLVHI LRPQDVYKRQGEG
CLLYTSCGRKMCTRDSEGA
CLLYTSCGRC.ICTRDRAW
LSLVHILRPQDVYKRQAVV
PVS CTHLAAARCVQETWI
LSLVHI LRPQDVYKRQI QD
CLLYTSCGRKMCTRDRDNS
CLLYTSCGRKMCTRIDSIKV
SCLLYTSCGRKMCT1flRI I
AVSCTHLAAARCVQETVIR
CLLYTSCGRKMCTRDRDYG
PVSCTHLAAARCVQETDGK
LSLVHI LRPQDVYKRQGDD
CLLYTSCGRKMCTRDSDCV
PVS CTHLAAARCVQETASR
AVS CTHLAAARCVQETGRQ
AVS CTHLAAARCVQETEDE
CLLYTSCGRKMCTRDRDED
Positions are based on the protein sequence of wild-type HW-1 N. An arrow
marks the insertion between the two amino acids indicated. Ail isolates are
independent insertions. 2Sequence of the 19 amino acid insertion. 3Disintegration
assay 4Strand-transfer assay 5Activity is based on WT IN activity. Symbols: 0%;
± O to 5%; if 6 to 35%; tif 36 to 75%, ff 76 to 100%
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FIGURE 2.3. Purification of wild type HW-1 iN and insertion mutant INs as observed
by 4—12% SDS-PAGE. M indicates the molecular weight markers. Lanes l-7, various
insertion mutant INs. Lane 8, wiid type IN.
2.4.4 In vitro Analysis of Individual HW- 1 IN Mutants
HW-l wild type iN and its mutants were assayed for strand transfer and
disintegration activities with LTR-specific substrates. Strand transfer activities were
detected by the use of a precleaved duplex DNA substrate. Disintegration activities were
tested by a Y-shaped substrate that resembies an integration intermediate.
Oligonucleotides used in the synthesis of the substrates in these experiments are listed in
Fig.2.4B.
N-terminal domain mutants. The HW-1 N-terminal domain is made of a
three-heiix bundie structure. Two of the insertions at N27L retained full disintegration
activity however their integration activity was barely detectable. Notably, these two
mutants were inserted into same position, but with different amino acids sequences.
Insertions D55C and P58G fali into the hinge region between HHCC domain and core
domain. In the two-domain crystal structure, which was crystaliized in a tetrameric form,
this connecting region (residues 47—55) is disordered in ail four monomers [125]. These
two insertions have retained high disintegration activity and have moderate to full
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integration activity. The D55/C56/S57 sequence is proposed to be involved in close
proximity with the HIV LTR positions 1-4, based on a structural tetramer model [126].
Core Mutants. In the core domain, insertions D64_C, 173_L, Y83_L, E96_T,
T125_V A12$A and W13 1W had completely diminished or very Iow
disintegration and integration activity. These insertions are located within elements
of secondary structure of the highly compact core consisting of a five-strand sheet
together with six helices. These insertions most likely will disrupt the secondary
structure. Insertions T115D and D116_N also completely diminished both
disintegration and integration activity. Two of the insertions are located in the loop
between $4 and cr2, and hence, would flot be expected to disrupt the packing of the
core domain. Because D116 is part of the catalytic triad, these two insertions most
likely disrupt the conformation of the catalytic triad. A group of insertions - 1135_K,
N144P, S 147_Q and G149 V — had different levels of disintegration activity, from
trace or weak to moderate disintegration activity, and are ail located near the loop
between $5 and a4. This agrees with a mutagenesis study on the Gly residues at 140
and 149 impaired catalysis of HIV-1 IN. Another group of insertions (V165_R,
D167Q, A169 E and E170 H, K173 T and T174A), which retained weak or trace
or no disintegration activity, are located in the loop between a 4 and a 5. These two
loop regions correspond to an extended loop (residues 137-156) and a flanking
region (residues 161-173), which are protected from proteolysis upon metal binding
[127]. Insertions A196G 1200V, V201 D, A205 T, D2071 and E212 are
distributed within o6. The activities of these insertion mutants range from low
disintegration activity to low to moderate integration activity as one moves toward
the C-terminai end of the lieux. 0f considerable interest, insertion E212L,
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maintained nearly full disintegration and integration activity.
C-Terminal domain. The C-terminal domain bas been suggested to be
involved in target DNA binding as mutations in this domain can abolish nonspecific
DNA binding [128, 129]. Insertion R228 D is located at the end ofj3l strand in the
C-terminal domain, and S230_R is located in the hairpin connecting t31 and f32.
Neither of these two mutants had strand transfer activity and both had greatly
decreased disintegration activity. Since the C-terminal 1N can tolerate large deletions
and can stiil have considerable level disintegration activity [33, 130], this implies
that the effect of these two mutants may flot simply be in disruption of folding of the
C-terminal domain.
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32p 5 E CAGT 3’ HIV-1 (U5)
__________________
GTCA
A 5’ A 5’ ACTGCTAGAGATTtCCACAT
processing 6 5’ ATGTGGAAAATCTCTAGGGCTGCAGGTCGAC
C 5’ CAGCAACGCAAGCHGF CA 3’
3• GTCA
D 5’ GTCGACCTGCAGCCCAAGCTTGCGHGCTG
A E 5’ AHGGAAAATCTCTAGCAGT
Disinteraon Strand transfer F 5’ AHGGAAAATCTCTAGCA
c c “>1-c32p 5’ 1—CAGT 3
_______
GTCA
D
FIGURE 2.4.(A) Schematic representation of the enzymatic activities catalyzed by the
retroviral fl’1 in vitro: 3’-processing; strand transfer; disintegration. Strand transfer
substrates are prepared by hybridizing the 32P-labeled F strand with the A strand. The
substrate is identical to the 3’-processing substrate, except for the absence of two
terminal nucleotides proximal to the CA dinucleotide. Strand transfer activity generates
products both larger and smaller than the substrate, since integration occurs at random
sites along the phosphate backbone of the target substrate DNA. The disintegration
substrate represents a hypothetical strand transfer intermediate. The substrate is prepared
by hybridizing the 32P-labeled C strand with the A, B, and strands. Disintegration
reaction resuits injoining ofthe 3’-OH end ofthe C strand to the B strand, resulting in
formation of the 30-nucleotide product. (B) Nucleotide sequences of HW-1 LIR
substrates used in the assays.
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FIGURE 2.5 (A) Integration activities ofthe mutant iNs. (B) Disintegration activities of
the mutant INs. Enzymatic activities of the mutant INs were assayed as described
under Experimental Procedures using HW-1 U5 LTR-derived substrates (Fig. 2.4 3).
Enzymatic activity is shown for integration (Panel A, lanes 1-10); and disintegration
(Panel B, lanes 1—11) Assays were done in 15 d reaction volumes with a final substrate
concentration of 0.07 pmol/ml. Reaction with substrate in the absence of protein is
represented in lane 1. In A and 3, reactions were incubated at 37 oc for 60 min and
terminated with proteinase K treatment for 30 min at 37°C.
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HI V-1 IN FLO GlO KAQEEIEKTHSNWRÀNASD FNLP PWAIŒIVAS C DKC Q LKQEAI
T ?fu T82 T83 a1 100
HI V-1 IN HQQVD C Z P QIWQLD C71!L E QKVILVAWWÀ ZQflEAEVI PAETQQ TAYF
ioial 84ff a2 a3fl T? T T!’415o
HI V-1 IN L LKLAQRWPVK1VffDNQ SNFTSflVKAA CWWAQIKQE FOI PYNP Q Z Q 0V
151 a4 TT a5 fa6 T200
HI V-1 IN lE ZNI’IICE LflCI I QQVPD Q AEHLKTAVQMAVFIIU’WKRKGQI QQYZÀQERI
HI V-1 INLIA!QTIS QKQ ITRI QNFLS 51T PVWTCQPLI
25fl134faB5 T? fftss
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FIGURE 2.6. Positions of each insertion (indicated by arrow) and their activity (using
different color scheme) relative to disintegration (circle) and strand transfer activity
(square) are shown for the amino acid sequence of 11W-l N protein. Numbering from
the N-terminus of HIV-1 N. Known structural elements of HW-1 N, determined by
crystallography of recombinant HW-1 N [125, 131], are also shown (bold horizontal
unes) above the respective homologous segments. Their PDB accession numbers are
1K6Y and lex4, respectively. ‘HHCC’ and ‘DDE’ motifs are highlighted in red.
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FIGURE 2.7. A three-dimensional structural model of the HW-1 monomer. The
location of the insertional mutations and their subsequent effects on disintegration and
strand transfer activity are shown using the color scheme corresponding to Fig.2.6. The
large spheres denote disintegration activity and the widened colored linear portions
denote strand transfer activity.
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Insertions afier amino acids 239 (mutants A239 K, K240 L, W243_K, and G245E
in f32; V250 I, 1251 Q in f33, D253_N and S255_D in ioop between 3 and f34,
V259V in f35) ail lost strand transfer activity while exhibiting full or slightly
decreased disintegration activity. This agrees with the observation that the
C-terminal deletion of 25 or 45 amino acids resuits in complete loss of integration
and 3’-processing activities [33] and also agrees with the observation that the
C-terminal deletion mutants (1-24$, 55-248, 1-206) exhibit higher or same level
activities in disintegration [130]. Mutant G247_A was an exception as it retained
full integration activity and disintegration activity. lnterestingly, the insertions in t32
and t33, which are right before and after 247 had no integration activity and were
decreased in disintegration activity. Insertions afler 126$ and before Q2$4 had
similar levels of activity in disintegration and retain moderate activity compared to
wild type N. This agrees with the observation that deietion of 15 amino acids from
end of the C-terminal domain retain similar or slightly reduced 3 ‘-processing
activities and decreased integration activities in the presence of Mn2 (but not
Mg2 )[33]. Insertions after R284 retain full activity both in the disintegration and
integration reactions. This again agrees with the observation that C-terminai deletion
of 5 amino acids exhibited wild type levels of 3’-processing activity and partial
activity ofintegration in the presence ofMn2 (but flot Mg2[33].
In summary, three regions retained full integration activity in this in vitro
study of HIV-1 IN. These correspond to the linge region connecting the N-terminal
and the core domains, within the helix connecting the core and C-terminal
domains, and the extreme C-terminus of the N.
2.5. DISCUSSION
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The retroviral genome has evolved to encode multifunctional proteins expressed
within polyproteins. These compact viral particles must assemble, infect, replicate
and integrate the viral genome using limited enzymatic functions. In this study, we
have used a transposon based mutational system (Tn5) to create a functional map of
the HIV-1 iN protein. Analysis of 57 insertional mutations in HW-1 IN indicates the
presence of limited, non-essential regions tolerant of amino-acid insertions. These
localize to protein and domain boundaries between the N-terminus and the core of iN,
at the C-terminus of iN and between the core and C-terminus of IN. Although
these results are non-saturating, the data indicate functional conservation even within
disordered regions within crystallographic structures.
The effects of insertion mutants in these studies are in general agreement with
previous biochemical studies. For example, the N-terminal 39 amino acid deletion
mutant completely abolished 3’-processing and integration activity [33]. We
observed that insertions at N27_L almost abolished integration activity. The loss of
integration activity agrees with the previous observations that showed that a
monoclonal antibody which bound to amino acids 27-29, destabilizes the helix
bundie and decreases both 3’-processing and transfer activities of HTV-1 IN in vitro
[132]. N27 is located at one end of helix bundie in the loop connecting the second
and third helices ofthe HW-1 iN N-terminus. The third a-helix contains amino acids
C (40), C (43) which interact through Zn with H (12), H (16) in the loop connecting
first a-helix. The substitution of Asn for Ris-12 rendered HW-1 defective at the
replication step in vivo. In contrast,zinc binding, 3’-processing and strand transfer
activities were reduced only a few fold from those of wild-type IN in vitro t133].
The mechanism by which the insertions, antibody and amino acids substitutions may
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ali act is through destabiÏization of the helix bundie.
The effects of insertions (1135K, N144 P, S147 Q and G149 V ) within the
surface loop (residues 141-14$) agrees with a previous observation that substitution
of Gly residues at 140 and 149 with more constrained Ala residues impaired catalysis
of HIV-1 IN, suggesting that the degree of conformational flexibility at these
positions is correlated with catalytic activity [17]. These two loops are believed to
undergo significant movement in order to aid in the coordination of a metal ion by
the catalytic triad [134, 135]. It is likeÏy that the insertions in these two loops prevent
the conformation change of these loops upon the metal binding. lnterestingly,
residues 16$-171 are also reported to interact with the host factor LEDGF [136].
E212L, which retains both activities at a good level, is within the region
connecting the C-terminus and core, and consists of an extended alpha-lieux with a
bend, or kink, at the center. This resuit suggests that considerable flexibility in the
linkage between the catalytic core and C-terminal domain can be functionally
tolerated since the net result of the 19 amino acid insertion would be to lengthen the
distance between the two domains and/or increase the discontinuity of the extended
aipha-helix. This agrees with the observation in the solved two domain structure of
the catalytic core and C-terminal of HW- 1, SIV- 1 and RSV IN, in which the
arrangement of the C-terminal domain relative to catalytic core differs among these
structures [30, 131, 137]. Similarly, disintegration requires only the core domain
(residues 50-126 [39]). Results from these studies are in agreement, with our
resuits that showed disintegration was diminished with insertions between D64_C
and S230R.
Insertions R22$ D and S230R, within the C-terminal domain, are interesting in that
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their losses of the disintegration activity are more than resuit from the entire deletion of
C-terminal domain of IN. In a tetramer model of IN, these two sites flank the target DNA
and are also very close to both viral DNA ends [138]. This suggests that these two
insertions may prevent or distort target DNA and/or viral DNA access. Insertions afler
amino acid 239 generally agree with the previous C-terminus deletion studies in both
disintegration and integration activities. Interestingly, the insertion G247_A retains
both full disintegration and integration activities, whose placement seemingly does not
present any structural interference on a tetramer model of HW-1 IN [126], but may
interfere with some amino acids in LEDGF when bound to HW-1 and placed in a
molecular mode! of the HW-l tetramer plus LEDGf (Monica Roth, personal
communication). It would be interesting to test the effect of this insertion mutant in vivo.
full activities in both disintegration and integration reaction of insertions afier amino
acid 284 suggests that the extreme C-terminus of the iN protein is non-essential, which
has been reported previously [1281 [33]. Although it is possible that the linkers are
substituting for natural amino acids at that position, we did not observe instances where
two in-frame insertions at the same position resulted in differentia! effects toward HW-1
IN function. This might have been predicted, as the insertions frequently encode Cys,
which could alter the protein folding. In this study, insertions at the same coding
sequence were identified that behaved identically, indicating there was not a positive
selection for a Cys residue to, for example, stabilize the region. The two insertions at
D55C encode LSLVHILRPQDVYKRQQVD and CLLYTSCGRKMCTRDRQVD and
at V250 I CLLYTSCGRKMCTRDRAVV and LSLVHILRPQDVYKRQAVV.
One aim of this mutational analysis was to identify sites within the IN protein
that may tolerate small insertional tags whose function may alter the target-site selection
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of the viral INs. Protein domains and tags have been inserted both into the N-terminus
[139-141] and C-terminus [140-145] of retroviral IN constructs. The identification
of the regions between the N-terminus, the core and C-terminus of IN as functional in
the presence of a variety of linker-insertions strongly suggests that this region could
serve as a third potential insertion site for short tags within the IN protein. The ability of
this site to function in alternative protein-protein or protein-DNA interactions depends
on its accessibility within the synaptic complex. Further biochemical and structural
studies are required to address this question.
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Chapter III
Comparison of Two Available Tetramer Models
3.1 Introduction
Although no fiul-Ïength experimental structure of HW-1 IN is available, structures
of each individual domain and two consecutive domains of HW-1 integrase are
available, as discussed in Chapter 2. However, these resuits by themselves are
fragmentary and much less direct experimental evidence exists for overali quaternary
structure of iN in vivo. Clearly, knowledge of the quatemary structure is required in
order to better understand how integrase recognizes and binds it cognate DNA targets
and also to target drug design to the appropriate solvent-exposed surfaces.
To date, there exists sufficient evidence indicating that functional N acts as a
multimer, most likely as a tetramer. Previously, two tetramer models were proposed
based on biochemical experiments and detailed structural information [13, 138]. The
question we address in this chapter is: how do these models agree with, or differ from
each other? How well do these models comply with the available experimental data? To
this end, the coordinates of the models, henceforth referred to as Model A [13] and
Model B [138] were obtained from the originating authors or downloading from the
Protein Data Bank. They were compared with each other as well as with the reported
biochemical resuits.
3.2 General description of Models A and B
The active form of HW- 1 IN is likely to be a tetramer, as suggested by previous
47
48
biochemical and structural studies (described in Section 1.1.5). The final form of both
Mode! A and Model B is tetrameric. Model A: composed by the superimposition of the
crystal structures of the dimer of HIV-1 1N52288 (PDB code 1EX4) and the dimer of
HW-1 N’212 (PDB code 1K6Y), modelled with viral DNA in canonical form, without
metal and target DNA. Model B: composed by assembly of the NMR monomer structure
of HIV-1 IN’7 (PDB code 1WJA), and the monomer X-ray crystallographical structure
of HW-1 1N56209 (PDB code iBIS), HIV-1 1N21927° (PDB code 1IHV), modeled with
viral DNA and target DNA in canonical form, without metal.
N
FIGURE. 3.1. Comparison of the integrase monomer structure of model A (panel A)
and model B (panel B). Three domains of the integrase monomer are shown in different
colors: N-terminal domain is in red, core domain is in green, and C-terminal domain is in
blue.
A
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FIGURE. 3.2. Model A of HIV-1 integrase tetramer complexed with viral DNA. The
integrase domains are colored as in Fig. 3.1. The viral LTRs are colored as dark orange
DNA strands. The host DNA is flot present in the model. Two views of the same
complex are presented. (A) Front view. (B) Back view.
A E
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FIGURE. 3.3. Model B of HIV-1 integrase tetramer complexed with DNA. The
integrase domains are colored as in Fig. 3.1. The viral LIRs are colored as dark orange
DNA strands. The host DNA is in purpie. Two views ofthe same complex are presented.
(A) Front view. (B) Back view. Adapted from Figure 4 of A.A.Podtelezhnikov,
et.al.[146].
3.3 Detailed comparison of tetramer Models A and B
Model A takes advantage of two resolved multiple-domain structures ofHIV-1 integrase,
namely the catalytic core with C-terminal domain structure, and the N-terminal domain
and catalytic core structure. This model is based on superposition of the conserved
catalytic core of the two two-domain structures, which resuits in a structurally plausible
full-length integrase dimer. In the case of model B, complete integrase structure
modeling is based on the structures ofthree separate domains.
Structural comparison of different integrases indicates considerable flexibility in
the linkage between the N-terminal domain, the C-terminal domain and the catalytic core
[12, 30]. We may think this flexibility makes definitive modeling of the complete
50
51
integrase structure from three separate domains difficuit and that two models constructed
independently would be substantially different. However, the constmcted modeis resuit
in similar tetramer structures, both of which have similar key interactions between iN
residues and the viral DNA observed experimentally. The main difference is that, overali,
the N-terminal domain and the C-terminal domain in Model A do flot pack against the
core domain as tightly as in Model B. This is particularly noticeabie for the C-terminal
domain in Model A, which has no interaction with the core domain at ail, while it is not
the case in Model B.
3.3.1 Juxtaposition of the core domain and the C-terminal domaîn
The spatial arrangement of the C-terminal domain relative to the core domain in Model
A is based on the resolved crystal structure of the core domain + C-terminal domain. On
the other hand, Mode! B takes advantage of measurements using time-resolved
fluorescence anisotropy (TFA) [146] to estimate the separation between the centers of
mass of the domains. However, TFA does flot imply anything about the relative
orientation of the integrase domains. Furthermore it is only the range of the rotational
correlation times that was determined in the TFA experiments and one can question the
validity of modelling the integrase quatemary structure at higher resolution based on
results ofTFA. However, we can’t exclude the close interaction between the C-terminal
and core domains, since the C-terminal domain can contact the core domain, as in the
case ofRSV integrase [30]
3.3.2 Role of DNA in construction of Models A and B
Mode! A was constructed using the two-domain structures that were resolved in
absence of viral or target DNA. Model A may thus only reflect the conformation and
spatial arrangement ofthe domains in absence of viral and target DNA; as there is
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evidence that binding of DNA can trigger conformational changes[89]. Model B
was careftilly examined against the data from cross-linking and footprinting experiments
in the presence of viral/target DNA[146], increasing the likelihood of producing a
reasonable model of the conformation and the arrangement in the presence of viral/target
DNA. But again, it is a complex network of DNA binding rather individual domains
that are unilaterally responsible for binding ofHIV-l IN to viral or target DNA; as
a resuh, crosslinking data offer difficuities to interpret for modeling.
Model B was constructed with application of some structural constraints. However,
some of the constraints may be arbitrary. For example, when building the tetramer from
two dimers, the authors proposed that the interface between the dimers should have
extensive contacts between them. While this hypothesis is plausible, there is no clear
evidence for this; in addition, in the absence of clear knowledge about the DNA binding
sites, it is difficuit to conclude on the protein-protein interfaces. Furthermore, the
C-terminal or / and N-terminal domains were placed to be involved in this interface as
mucli as possible, which is not very useful and practicable for higher resolution
modeling [146]. It should be noted that, despite the different considerations used for
building the two models, the N-terminal domain and the C-terminal domain are close to
each other in three dimensions in both models.
Neither Model A nor Model B is composed of ail 28$ residues of the full-length
enzyme, nor are there any metal ions. The distance between the two active sites in the
dimers constituting Models A and B are 40 Â and 33 À, respectively. This distance is
much greater than the five base pair spacing of the insertion sites of the two viral DNA
ends into the target DNA, which is in the range of 15 Â to 20 Â (depending on the
conformation of the bound DNA). This observation is consistent with the proposal of a
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tetrameric (or higher order) structure for IN, to allow the required proximity of active
site elements via multimerization. Both models place the viral DNA along a contiguous
strip of positiveÏy charged residues starting from catalytic site of one monomer and
extending to the C-terminal domain of another monomer, which comply with the “trans
to the active site” activity that lias been observed [12, 43, 89]. The strips include
residues K159, K186, R187, K188, and extends out to K211, K215, and K219 ofthe a6
helix. For example, both models place K159 close to the same adenosine nucleotide in
viral DNA. However, there is a minor but important difference: in model A, the side
chain of E152 approaches the backbone of the conserved adenosine nucleotide at the
3’-end directly adjacent to the cleaved site in the viral DNA (the 3’-CA motif). This is
consistent with the previous experimental conclusion that E152 plays a role in the
specific recognition of that specific AIT base pair from studies undertaken to identify
amino acids that determine substrate specificity [84]. On the other hand, E152 is far
away from conserved adenosine nucleotide at the 3’-end viral DNA in Model B. Residue
E246 in the C-terminal domain binds near position five of the lower strand in the viral
DNA in Model B, which is confirmed experimentally [89], while there is a 20 À distance
between the viral DNA and F246 in Model A. These points illustrate that neither Model
A nor Model B takes into account ail the previous experimental data.
3.3.3 Biological relevance of the models
After the models were constructed, the next question is: how biologically
relevant are these dimer-of-dimers models? Model B can potentially explain the effects
of the F185K substitution in HW-1 integrase, which makes integrase more soluble and
this effect rnight prevent correct formation of the integrase tetramer [64] and disrupt
integration in vivo and in vitro [97, 138]. Model B places this residue in the interface of
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two integrase dimers. Additional support for Model B cornes from structural simiiarity
of this model with the homologous Tn5 transposase—DNA complex recentiy resolved by
X-ray crystallography [147]. Model A is aiso reminiscent of the structure of Tn5
transposase dimer in complex with its DNA substrate. Both models are similar to the
Tn5 structure.
The major concem about the functional relevance of tetrameric Model A is that
its construction is based on the spatial arrangement of four monomers of the
C-terminally truncated HIV-i 1-212 as observed in its crystallographic structure.
However, gel filtration shows that this same HW-1 N1212 fragment is exclusively
dimeric at physiological sait concentrations, casting doubt on the physiologicai
relevance ofthe dimer-dimer interface observed in the crystal structure ofHW-1 1212
However, tetramers may exist with the full-length integrase protein since the C-terminal
two-domain protein (1N50288) forms both dimers and tetramers in solution [97], pointing
to a crucial role for the C-terminal domain in tetramerization.
3.4 Integrating the data from the insertion al mutations into the mode]s
Most mutants we made were inactive for both disintegration and strand-transfer
activities (refer to Chapter 2, particulariy Table 1). It is impossible to teli whether the
inactivity of our mutants is due to structural disruption or whether the bulky insertions
prevent specific interactions such as 1N-DNA, monomer-monomer, or dimer-dimer
interaction, without further characterization of IN mutants. Our resuits and existing
experimental data indicate important functional conservation even within disordered
regions of the crystallographic structures: for example, substitution of G1y140 and 149,
which is in the loop between 35 and a4 with more constrained Ala residues, impaired
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catalysis of HIV- I IN [1 7j. For this reason, we will focus on the active mutants and only
the active mutants were analyzed against Model A and Model B.
Two insertions obtained at N27L, which is located at one end ofthe helix-bundie in
the loop connecting the second and third a—helices of the HW- 1 IN N-terminus, almost
abolished integration activity. These two insertions produce steric hindrance in the
tetramer of model A and B. Specifically, these insertions disrupt N-terminal domain
dimerization in Model B and interfere protein-protein interaction between N-terminal
and C-terminal domain in Mode! A (Fig. 3.4 and Fig. 3.5). Our resuits provide indirect
evidence that integration activity requires higher order complex formation while
disintegration requires only a dimeric or even a monomer state since insertions N27_L
retain full disintegration activity. We postulate that they also might interfere with an
essential conformational change induced upon zinc binding. Previous studies showed
that in the presence of Zn2, the HW- 1 IN multimerizes from a dimer to a tetramer,
which miglit be essential for the integrase activity in vitro [45].
Insertions (D55_C and P5 8_G) in the hinge between the N-terminal domain and the
core domain are active in both disintegration and integration activities. Placing
insertions in this region thus causes no interference with DNA binding or intramolecular
and intermolecular interactions in model B, but not model A, in which the insertions will
prevent the docking oftarget DNA (Fig. 3.6 A and B).
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FIGURE. 3.4 Insertions N27L, E212 L and G247 A in the context of model A of
HIV- 1 integrase tetramer complexed with viral DNA. The integrase domains are colored
as in fig. 3.1. Amino acids neighboring the insertions are shown as space-fihling
residues. The viral LTRs are in orange. The host DNA is flot present in model A. The
imagine was generated with MSIVIEWLAB.
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FIGURE 3.5 Insertions N27L, E212 L and G247_A in the context of model B of
HIV-1 integrase tetramer complexed with viral DNA and host DNA. The integrase
domains are coÏored as in Fig 3.1. Amino acids neighboring the insertions are shown as
space-fihled residues. The viral LTRs are in orange. The imagine was generated with
MSWIEWLAB.
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FIGURE. 3.6. Insertions D55_C and P5 8_G in the context of model A (Panel A) and
model B (Panel B). The integrase domains are colored as in Fig. 3.1. Amino acids
neighboring the insertions are shown by orange space-fihled residues. The viral LTRs are
shown as orange DNA strands (panel A) or yellow DNA strands (panel B). The host
DNA is not present in the mode! A. The imagine was generated with MSIVIEWLAB.
A
55C and P58G
D55C and P58G
B
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The insertional mutant E212_L maintained nearly full disintegration and integration
activities. E212 L is within the region connecting the core domain and the C-terminal
domain, which consists of an extended aipha-helix (a6) with a bend, or kink, at the
center. Inserting the amino acids at position 212 in both model A and model B does flot
interfere with DNA binding or its intramolecular and intermolecular interactions. The
presence of a kink in one of the two a6 helices (thus, the dimer is asymmetric) which is
near a knoWn proteolytic site, as well as this new data showing tolerance to insertions,
suggests that the two a6 helices are flexible during the integration process.
G247_A mutant retained full integration and disintegration activity. The context of
G247 differs in Model A and B. Insertions of 19 amino acids in Model B would predict
disruption of the interaction between the two C-terminal domains with the two core
domains, whereas within the tetramer of Model A, this position is modeled away from
the dimer interface of two C-terminal domains as well as the site of DNA binding. Our
resuits are consistent with this tetramer model.
Since both models have only 270 amine acids, the insertions afier D270 can net be
positioned into the tetramer models, but by virtual extension of D270, we can predict
that the insertions afler D270 would flot disrupt the interaction between both
intermolecular, intramolecular of ll\T, and viral and host DNA, which is consistent with
experimental results in both MuLV iN (M. Roth and coworkers) and HW-1 iN (this
study).
Conclusion: Model A and model B are both tetramer models, model A may be
preferred in the spatial arrangement of the N-terminal and C-terminal demain relative te
the core domain since this model is based on superposition of the conserved catalytic
core of the two two-domain structures, which results in a structurally plausible
59
60
full-length integrase dimer. The model B is preferred in the placement of viral and target
DNA since their positioning are based on solid biochemical data and target DNA is
absent in model A. Our insertion G247_A would favor the arrangement of C-terminal
domains in model A. From a general point of view, both models we compared might flot
be the only possible solutions to the tetrameric arrangement of HIV-1 IN. Other
inter-domain arrangements forming full-length monomers and inter-monomer
arrangements forming dimers and tetramers or octamers are also possible. Nonetheless,
our data provides important insights complementing other previously reported work on
the assembly of functional HW-1 IN.
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Chapter IV
Discussion
Retroviruses are characterized as simple or complex based on the organization of
their genomes, although this is flot a taxonomie classification. All retroviruses contain
the three major coding domains, gag, pol and env, in their genome. While the simple
retroviruses (MuLV for example) carry only this elementary information, complex
retroviruses (HP!- 1, for example) carry additional regulatory proteins that are derived
from multiply spliced messages. IN proteins from different retroviral species vary in size
and amino acid homology [148] [48] [149]. Two regions of strong similarity are shared
between retroviral IN proteins, a proposed zinc finger motif or HHCC region in the
amino terminus, and a central core region containing the D, D (35)E motif. The
C-terminal portion of retroviral INs is the least conserved and has been functionally
characterized to be the site of nonspecific DNA binding. The M-MuLV iN is
approximately 14 kDa larger than HIV-1 and avian sarcoma-leukosis virus iNs. This
larger size of M-MuLV IN is accounted for by differences in its N- and C-termini.
Approximately 50 amino acids precede the HHCC domain of the M-MuLV IN, and the
C-terminus contains a unique 36-amino-acid insertion [148].
Several systems have been developed for “genetic footprinting” of a gene based
upon the generation of a library of random inserts and screening those pools for
selectable phenotypes. The systems are based on bacterial transposons including Tn5,
Tn7, and Mu, or viruses [104, 109, 150-153]. These systems have the potential to
screen the entire population of insertions before and after a selection process through
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positional mapping ofthe inserts by PCR.
Recent studies have demonstrated methods of comprehensive analysis of a gene by
constructing an entire set of mutants of the gene [105, 107]. In the process of developing
a complete functional map of the M-MuLV genome, a library of M-MuLV proviral
vector insertion mutants was generated using a linker scanning system by the research
group of Monica Roth at the Robert Wood Johnson Medical School, University of
Medicine and Dentistry of New Jersey. Afler mutagenesis, each proviral vector within
the iibrary contained a single 15 base pair insertion at a random location within the
target fragment. This mutagenized fragment, the 3’ terminai two-thirds of the pol gene,
included the last half of the reverse transcriptase (RT) reading frame the IN reading
frame. Ail insertions were identical and code for a unique Frne I restriction enzyme
site that was used for mapping studies of individual clones selected from the library, in a
manner similar to the work presented in Chapter 2 of this thesis. The effects of the
insertions were examined in vivo (Jennifer Puglia, Tan Wang, Christine Smith-Snyder,
Marie Cote, Michael Scher, Joelle Pelletier, Sinu John, Colleen B. Jonsson and Monica
J. Roth, manuscript in preparation) and are reported below in order to compare the
effects of the M-MuLV insertion mutants with the effects we observed for the HIV- 1
insertion mutants.
Regions in the MuLV pol gene were identified which functionally toierate
various linker-insertions. These correspond to the RT/1N proteolytic junction the
junction between the IN catalytic core domain and the C-terminal domain and the
C-terminus of IN (Monica Roth, personal communication).
Comparison of two related IN proteins between the in vitro HW-1 IN study
presented in Chapter 2 and the data obtained in the group of Monica Roth for the in vivo
62
63
MuLV IN study reveals a general agreement with respect to the function of the
C-terminus of the IN and the viability of insertions within the a6 helix (Fig. 4.1. and Fig.
4.2): the hinge region between the core and C-terminal domain and extreme C-terminal
amino acids can tolerate the insertions in both MuLV IN and HW- 1 IN.
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111V (1) -fLDGIDKAQEEIiEKYSNWRAMA5DFNLPPVV---
Mo-MLV (1) IENSSPVT5EIfFIlyTVTQIKDLTKLGAIYDKTKKYwvyQGKpVMpDQFTFELLDFLHQLTL5FSKMKALLER5Il5pyyM
un
TT T T
HIV (33) ---AKEIVAS---COKC---QLkG---—EAMHG0VDCSPGIWQLDcTHL6KVTL VAVHVASGYIEAEVIPAETG
Mo-MLV ($1) LNRORTLKNITETCKAÇAQVNASKSAVKQGTRVRGHRPC,THWEIDFTEIKPGLYGYKVLLVFIDTFSCjWIEAFPTKKETA
f 1 TT T T T T ‘ T
111V (95) QETA-VFLLKL--AGRWPVKTVHTNGSNFT5TTVKAACwwAGIKQEFGIPyNPQSQGVI[5MNgELKKIIGQV
MO-MLV (161) kVVTKKLLEEIFPRFGMP-QVCGTDNGPAFV5KVSQTVAOLLGIDKLI4CAyRpQS5GQVERMNRTIKETLTgLTLATcjS
rTTT TT T
111V f166) RDQAEHLKTAvQMAVFIHN IKRKCjGIG,YSAGERIVDIIATDIQTKÉLQKQ1TKiQNFRVVYR0SRDPv
Mo-MLV (241) RDWVLLLPLALYRAR---NTPGPHGcTPYEILGAPPPLVNFPDPDMTRVTNSPSLQAHLQALYLVQHEVWRPLAAAYQE
T 1f 1f
TTTT JTTT TT
111V (235) --
-- -WKGPAKLLWKGEGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDOCVASR
MO-MLV (321) QLDRPVVPUPYRVGDTVWVRRIIQTKNLEPRwKGPYTVLLTTPTALKV -DGIAAWIFIAAUVKAADPGGGPSSRL
TT D’.intcgraiion .Lctivity —
111V (285) QDED ±
Mo-MLV (401) TWRVQRSQNPLKIRLTREAP +
Stranci ttansfer activitv ++
+++
Figure 4.1. Positions of each insertion (indicated by arrows) and their activity
(using the indicated color scheme) relative to disintegration (circle) and strand transfer
activity (square) are shown in the alignment ofHW-1 (HIV) and MuLV (Mo-M-MULV)
IN proteins. The information for in vitro effects of HIV- 1 iN insertions are given ahove
its sequence. The information for MuLV IN insertions is given below its sequence:
upward-arrows indicate the sites of insertion resulting in viable viruses in the in vivo
MuLV iN assay. The amino acid sequence alignment ofMuLV and HW-1 IN was based
on Jolmson [154]. Dots indicate sequence aïignment gap/insertion. Numbering from the
N-terminus of MuLV IN includes alignment gaps. The GenBank accession number for
MuLV iN sequence is NC 001501. Known structural elements of HW-1 IN, determined
by crystallography of recombinant HW-1 IN [12, 13] are also shown (bold horizontal
lines) above the respective homologous segments. Their PDB accession numbers are
1K6Y and lex4, respectively. ‘HHCC’ and ‘DDE’ motifs are highlighted by red color.
The 14 amino acid region in MuLV IN (DPDMTRVTNSPSLQ), which is highlighted in
red, was found to be tolerant of 5 amino acid insertions in vivo. This region corresponds
to the HIV-1 iN sequence IATDIQFKELQKQI [14$].
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Figure 4.2. MuLV viable domain mapped onto the HW-1 Core-C-terminus structure
(1EX4). The 14 amino acid region in MuLV IN (DPDMTRVTNSPSLQ) was found to be
tolerant of 5 amino acid insertions in vivo. This region corresponds to the HW-1 IN
sequence IATDIQFKELQKQI [148], which is highlighted in red (A204-1217 of the A
molecule in 1 EX4 is taken from the two domain structure of HW- 1 Core+C-terminus
[12]). The HW-1 core domain is colored bÏue; the C-terminus is yellow. The figure was
generated in MOLSCRTPT V 2.0 [155].
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Due to the uneven distribution of the insertions within the two systems, some
questions remain open. The N-terminal 14 amino acids of the MuLV IN tolerated
insertions; however no insertions were identified within the extreme N-terminus of the
HW- 1 IN. It should be noted that the N-terminus of MuLV IN encodes 45 amino acids
flot conserved in either HW or ASV related INs [156]. The region tolerant of insertions
at the N-terminus of MuLV IN maps within this non-conserved region. As a resuit, the
data obtained for the N-terminus of MuLV IN does flot provide information with respect
to the predicted impact of insertions in the N-terminus of HW- 1 IN.
These studies, in vitro ofHW-1 IN and in vivo ofMuLV IN, do not allow the direct
comparison of the effects of linker-insertions in vitro and in vivo within the same virus.
These types of studies are of interest, as insertions tolerated in in vitro systems may be
interfering with host-interacting proteins in vivo, where additional interacting partners
may be required for full function. It is of interest that although functional
complementation of MuLV IN was achieved in vitro using constructs that stably
expressed the N-terminal zinc binding domain (IN1-105) with the core-C-terminus
two-domain fragment (IN 106-404) [157], no viable linker-insertion was identified in
vivo at the junction of the HHCC domain and the core domain (Jennifer Puglia, Tan
Wang, Christine Smith-Snyder, Marie Cote, Michael Scher, Joelle Pelletier, Sinu John,
Colleen B. Jonsson and Monica J. Roth, manuscript in preparation). However, in the
case ofthe in vitro HW-1 IN mutational study, three insertions at two positions (D55_C
and P5 8G) were identified at the transition between the HHCC and core domain, which
retain full activity in both disintegration and strand transfer activity of HW- 1 IN.
66
67
The boundary defining the insertion-tolerant region between the core domain and
the C-terminal domain is flot well defined in these two studies since a more saturated
library within this region would be required. Nonetheless, the 19 amino-acid insertions
obtained within HW-1 IN in this study and the 5 amino-acid insertions obtained within
MuLV IN ( Jennifer Puglia, Tan Wang, Christine Smith-Snyder, Marie Cote, Michael
Scher, Joelle Pelletier, Sinu Joim, Colleen B. Jonsson and Monica J. Roth, manuscript in
preparation) provide some insights into these boundaries. In MuLV IN, the region
encoding DPDMTRVTNSPSLQ corresponds to the HW-1 IN sequence
IATDIQFKELQKQI (Fig. 4.1 and Fig. 4.2). A deletion study of MuLV IN identified a
stable expressed C-terminal domain, the N-terminus of which mapped directly within
this region (Monica Roth and coworkers, personal communication), supporting this
region as a domain boundary. This suggests that the region should be tolerant of
insertions. Indeed, the insertion E212 L in HW-1, which retains both disintegration and
strand transfer activity, maps within the 12 amino acid region homologous to MuLV IN
(JATDIQFKELQKQI, where the EL are underlined), in the middle of the long Œ6 helix,
which connects the core and C-terminal domains [1311. Insertions C-terminal to the
observed bend tolerated insertions of both 5 and 19 amino acids, in vitro and in vivo in
the HIV- 1 and MuLV IN, respectively. The 19 amino acid insertion D207_I maps within
the region homologous to MuLV IN (IATDIQFKELQKQI, DI insertion site underlined),
yet is not active for disintegration or strand-transfer activity. Thus differences in the
boundaries between HIV-1 and MuLV IN were identified. This may reflect the
differences in the size of the insertions, where 5 amino acids are tolerated and 19 amino
acids are flot, or structural differences in the assembly of iN multimers. It is flot known
67
68
whether the insertions into this region present a favorable condition for the virus. In a
related insertional study of the Cre recombinase, insertions into the M-N linker increased
DNA binding cooperativity [158]. In that system, it was proposed that extending the
length of the linker would lead to a smaller bend angle and thus stabilize partner Cre
subunits binding to the loxP. In a similar manner, extending the distance between the
core and C-terminus may assist in the assembly of the synaptic complex consisting of
the two viral termini plus the target DNA.
The ability of retroviral particles to stably integrate into the host genome is a
great benefit for gene delivery, but the potential for insertional mutagenesis cannot be
overlooked [140, 141, 159, 160. Schemes to target integration into alternative
positions within the host chromosome ftequently involve generation of fusion proteins
with novel targeting domains {Bushrnan, 1995 #96, 161, 162]. The linker-insertion
genetic footprint provides a means to identify non-essential regions within proteins
capable of withstanding insertions.
Two models have been compared with the interaction of viral DNA with a multimer
of IN. The question that we would like to answer will be: is our experimental data
preferred by one model than other? Can the two models agree with our experimental
data? The two models both predict that our N-terminal insertion would affect the
activities of HW-1 IN, which agrees with our experimental data. Our C-terminal
insertion G247 A would favor the arrangement of C-terminal domains in model A.
Through both models, we would also predict that some of the loop regions within the
Core might be more amenable to mutation given the solvent accessibility shown in the
monomer and dimer structures, such as the loops between the N-terminal a3 and the Core
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f31’, the Core 5’ and a4’ and between the Core a5’ and c. While we did not expect
integration activity per se, we expected disintegration since this activity may not require
a higher order complex. However, in our studies, insertions located at the Core loops ail
lost integration activity and had no or barely detectable disintegration activity. This set of
mutants in core demonstrates the compactness of IN and underscores the complexity of
intramolecular and intermolecular interactions that IN must maintain during the
integration process.
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